Ticker

Analyst Price Targets — SQZ

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 1, 2022 8:48 amChardan Capital$4.00$1.82Benzinga Chardan Capital Maintains Buy on SQZ Biotechnologies, Lowers Price Target to $4

Latest News for SQZ

Serica Energy shares rise on bond financing talk

Serica Energy PLC (AIM:SQZ) shares traded higher on Friday, climbing 4.2% to 282.8p, after it announced it is preparing fixed income investor meetings for a possible five-year senior unsecured bond, as the North Sea producer looks to refinance drawn bank debt while preserving balance-sheet flexibility. The company said any bond issue would be subject to market conditions and suitable terms.

Proactive Investors • Apr 24, 2026
Financial Comparison: SQZ Biotechnologies (NYSE:SQZ) vs. Cortexyme (NASDAQ:CRTX)

Insider and Institutional Ownership 63.2% of Cortexyme shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 27.9% of Cortexyme shares are held by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments

Defense World • Mar 22, 2026
Cortexyme (NASDAQ:CRTX) and SQZ Biotechnologies (NYSE:SQZ) Critical Review

Profitability This table compares SQZ Biotechnologies and Cortexyme's net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets SQZ Biotechnologies -369.96% -119.83% -59.90% Cortexyme N/A -70.96% -63.53% Valuation and Earnings This table compares SQZ Biotechnologies and Cortexyme"s revenue, earnings per share (EPS) and valuation. Gross Revenue Price/Sales Ratio

Defense World • Mar 11, 2026
Head to Head Contrast: NKGen Biotech (NYSE:NKGN) and SQZ Biotechnologies (NYSE:SQZ)

Profitability This table compares NKGen Biotech and SQZ Biotechnologies' net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets NKGen Biotech N/A N/A -479.36% SQZ Biotechnologies -369.96% -119.83% -59.90% Valuation and Earnings This table compares NKGen Biotech and SQZ Biotechnologies"s revenue, earnings per share and valuation. Gross Revenue

Defense World • Feb 8, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for SQZ.

No House trades found for SQZ.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top